Vestal Point Capital, Lp Top Holdings and 13F Report (2024)

About Vestal Point Capital, Lp

Investment Activity

Vestal Point Capital, Lp has $1.32 billion in total holdings as of September 30, 2024.
Vestal Point Capital, Lp owns shares of 69 different stocks, but just 26 companies or ETFs make up 80% of its holdings.
Approximately 38.41% of the portfolio was purchased this quarter.
About 47.96% of the portfolio was sold this quarter.
This quarter, Vestal Point Capital, Lp has purchased 60 new stocks and bought additional shares in 22 stocks.
Vestal Point Capital, Lp sold shares of 17 stocks and completely divested from 16 stocks this quarter.

Largest Holdings

Insmed: $116,800,000
Jazz Pharmaceuticals: $100,269,000
Cytokinetics: $79,200,000
Inari Medical: $63,922,000
Arcellx: $56,369,250

Largest New Holdings this Quarter

Agios Pharmaceuticals: $33,766,800 Holding
BioMarin Pharmaceutical: $28,116,000 Holding
Avadel Pharmaceuticals PLC: $26,230,000 Holding
Biohaven: $24,985,000 Holding
Edwards Lifesciences: $18,147,250 Holding

Largest Purchases this Quarter

Insmed: 850,000 shares (about $62.05M)
Inari Medical: 1,200,000 shares (about $49.49M)
Agios Pharmaceuticals: 760,000 shares (about $33.77M)
BioMarin Pharmaceutical: 400,000 shares (about $28.12M)
Avadel Pharmaceuticals PLC: 2,000,000 shares (about $26.23M)

Largest Sales this Quarter

Ascendis Pharma A/S: 500,000 shares (about $74.66M)
Jazz Pharmaceuticals: 600,000 shares (about $66.85M)
Ultragenyx Pharmaceutical: 1,050,000 shares (about $58.33M)
Applied Therapeutics: 4,285,000 shares (about $36.42M)
Cytokinetics: 575,000 shares (about $30.36M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
INSM Insmed	$116,800,000	$62,050,000 ▲	113.3%	1,600,000	8.9%	Medical
JAZZ Jazz Pharmaceuticals	$100,269,000	$66,846,000 ▼	-40.0%	900,000	7.6%	Medical
CYTK Cytokinetics	$79,200,000	$30,360,000 ▼	-27.7%	1,500,000	6.0%	Medical
NARI Inari Medical	$63,922,000	$49,488,000 ▲	342.9%	1,550,000	4.8%	Medical
ACLX Arcellx	$56,369,250		0.0%	675,000	4.3%	Medical
GPCR Structure Therapeutics	$50,473,500	$25,895,100 ▲	105.4%	1,150,000	3.8%	Medical
KALV KalVista Pharmaceuticals	$46,320,000	$19,686,000 ▲	73.9%	4,000,000	3.5%	Medical
ATXS Astria Therapeutics	$44,040,000	$8,257,500 ▲	23.1%	4,000,000	3.3%	Medical
IMTX Immatics	$42,787,500	$11,410,000 ▲	36.4%	3,750,000	3.2%	Medical
RARE Ultragenyx Pharmaceutical	$41,662,500	$58,327,500 ▼	-58.3%	750,000	3.2%	Medical
ASND Ascendis Pharma A/S	$37,327,500	$74,655,000 ▼	-66.7%	250,000	2.8%	Medical
SLNO Soleno Therapeutics	$36,352,800	$24,235,200 ▼	-40.0%	720,000	2.8%	Medical
DAWN Day One Biopharmaceuticals	$34,825,000	$17,412,500 ▲	100.0%	2,500,000	2.6%	Medical
SVRA Savara	$34,301,600	$6,784,000 ▲	24.7%	8,090,000	2.6%	Medical
AGIO Agios Pharmaceuticals	$33,766,800	$33,766,800 ▲	New Holding	760,000	2.6%	Medical
XENE Xenon Pharmaceuticals	$32,480,250	$11,811,000 ▲	57.1%	825,000	2.5%	Medical
BMRN BioMarin Pharmaceutical	$28,116,000	$28,116,000 ▲	New Holding	400,000	2.1%	Medical
Avadel Pharmaceuticals PLC	$26,230,000	$26,230,000 ▲	New Holding	2,000,000	2.0%	COM SHS
BHVN Biohaven	$24,985,000	$24,985,000 ▲	New Holding	500,000	1.9%	Medical
QURE uniQure	$23,417,500		0.0%	4,750,000	1.8%	Medical
JANX Janux Therapeutics	$22,033,550	$10,903,200 ▼	-33.1%	485,000	1.7%	Medical
BDTX Black Diamond Therapeutics	$21,873,975	$12,738,975 ▲	139.5%	5,028,500	1.7%	Medical
SLDB Solid Biosciences	$19,516,000	$940,950 ▲	5.1%	2,800,000	1.5%	Medical
EW Edwards Lifesciences	$18,147,250	$18,147,250 ▲	New Holding	275,000	1.4%	Medical
GILD Gilead Sciences	$16,768,000	$16,768,000 ▲	New Holding	200,000	1.3%	Medical
LQDA Liquidia	$15,000,000	$3,300,000 ▼	-18.0%	1,500,000	1.1%	Medical
A Agilent Technologies	$14,848,000	$14,848,000 ▲	New Holding	100,000	1.1%	Computer and Technology
BMY Bristol-Myers Squibb	$12,935,000	$12,935,000 ▼	-50.0%	250,000	1.0%	Medical
GSK GSK	$12,264,000	$12,264,000 ▲	New Holding	300,000	0.9%	Medical
Bicara Therapeutics Inc	$10,824,750	$10,824,750 ▲	New Holding	425,000	0.8%	COM
Dianthus Therapeutics Inc	$10,815,100	$5,612,900 ▼	-34.2%	395,000	0.8%	COM
CRNX Crinetics Pharmaceuticals	$10,475,500	$10,475,500 ▲	New Holding	205,000	0.8%	Medical
ITOS iTeos Therapeutics	$10,465,250	$7,402,250 ▼	-41.4%	1,025,000	0.8%	Medical
APLT Applied Therapeutics	$9,732,500	$36,422,500 ▼	-78.9%	1,145,000	0.7%	Medical
NRIX Nurix Therapeutics	$9,549,750	$1,685,250 ▼	-15.0%	425,000	0.7%	Medical
SNY Sanofi	$8,644,500	$8,644,500 ▲	New Holding	150,000	0.7%	Medical
BRKR Bruker	$8,632,500	$8,632,500 ▲	New Holding	125,000	0.7%	Computer and Technology
Apogee Therapeutics Inc	$8,018,010	$8,018,010 ▲	New Holding	136,500	0.6%	COM
ZYME Zymeworks	$7,718,250	$2,196,250 ▲	39.8%	615,000	0.6%	Medical
Lexeo Therapeutics Inc	$7,684,000	$90,400 ▲	1.2%	850,000	0.6%	COM
TARS Tarsus Pharmaceuticals	$7,564,700	$7,564,700 ▲	New Holding	230,000	0.6%	Medical
Alto Neuroscience Inc	$7,436,000	$343,200 ▲	4.8%	650,000	0.6%	COM SHS
BDX Becton, Dickinson and Company	$7,233,000	$7,233,000 ▲	New Holding	30,000	0.5%	Medical
MDGL Madrigal Pharmaceuticals	$6,366,600	$6,366,600 ▲	New Holding	30,000	0.5%	Medical
LEGN Legend Biotech	$6,091,250	$6,091,250 ▲	New Holding	125,000	0.5%	Medical
FATE Fate Therapeutics	$5,897,500	$1,102,500 ▼	-15.8%	1,685,000	0.4%	Medical
GLPG Galapagos	$5,182,200		0.0%	180,000	0.4%	Medical
URGN UroGen Pharma	$5,080,000	$5,080,000 ▲	New Holding	400,000	0.4%	Medical
GLUE Monte Rosa Therapeutics	$4,929,000	$212,000 ▲	4.5%	930,000	0.4%	Medical
GERN Geron	$4,767,000	$4,767,000 ▲	New Holding	1,050,000	0.4%	Medical
PASG Passage Bio	$4,270,000	$33,600 ▲	0.8%	6,100,000	0.3%	Medical
ALLO Allogene Therapeutics	$4,200,000	$1,960,000 ▼	-31.8%	1,500,000	0.3%	Medical
PRME Prime Medicine	$4,140,900	$2,399,400 ▲	137.8%	1,070,000	0.3%	Medical
VTYX Ventyx Biosciences	$3,760,500	$893,800 ▲	31.2%	1,725,000	0.3%	Medical
ZVRA Zevra Therapeutics	$3,643,500	$3,643,500 ▲	New Holding	525,000	0.3%	Medical
ARDX Ardelyx	$3,445,000	$3,445,000 ▲	New Holding	500,000	0.3%	Medical
PTCT PTC Therapeutics	$2,968,000	$371,000 ▼	-11.1%	80,000	0.2%	Medical
PEN Penumbra	$2,914,650	$2,914,650 ▲	New Holding	15,000	0.2%	Medical
VYGR Voyager Therapeutics	$2,866,500	$643,500 ▼	-18.3%	490,000	0.2%	Medical
MGNX MacroGenics	$2,730,700	$98,700 ▲	3.8%	830,000	0.2%	Medical
VERV Verve Therapeutics	$2,541,000	$121,000 ▲	5.0%	525,000	0.2%	Medical
ITCI Intra-Cellular Therapies	$2,195,100	$2,195,100 ▲	New Holding	30,000	0.2%	Medical
ESTA Establishment Labs	$1,730,800	$1,730,800 ▲	New Holding	40,000	0.1%	Medical
RLMD Relmada Therapeutics	$1,587,600	$2,300,400 ▼	-59.2%	490,000	0.1%	Medical
ACHL Achilles Therapeutics	$1,530,000		0.0%	1,500,000	0.1%	Medical
RPHM Reneo Pharmaceuticals	$1,358,980	$432,480 ▲	46.7%	799,400	0.1%	Medical
CMRX Chimerix	$1,302,000		0.0%	1,400,000	0.1%	Medical
Atara Biotherapeutics Inc	$1,013,624	$103,064 ▲	11.3%	124,677	0.1%	COM NEW
Tenax Therapeutics Inc	$288,332	$288,332 ▲	New Holding	83,333	0.0%	COM NEW
GMED Globus Medical	$0	$61,641,000 ▼	-100.0%	0	0.0%	Medical
BGNE BeiGene	$0	$49,934,500 ▼	-100.0%	0	0.0%	Medical
EXAS Exact Sciences	$0	$39,081,250 ▼	-100.0%	0	0.0%	Medical
AXSM Axsome Therapeutics	$0	$24,150,000 ▼	-100.0%	0	0.0%	Medical
ALXO ALX Oncology	$0	$21,708,000 ▼	-100.0%	0	0.0%	Medical
Praxis Precision Medicines Inc	$0	$18,198,400 ▼	-100.0%	0	0.0%	COM NEW
APLS Apellis Pharmaceuticals	$0	$12,850,600 ▼	-100.0%	0	0.0%	Medical
IMNM Immunome	$0	$12,100,000 ▼	-100.0%	0	0.0%	Medical
DNLI Denali Therapeutics	$0	$11,610,000 ▼	-100.0%	0	0.0%	Medical
BNTX BioNTech	$0	$8,036,000 ▼	-100.0%	0	0.0%	Medical
INSP Inspire Medical Systems	$0	$8,029,800 ▼	-100.0%	0	0.0%	Medical
PCRX Pacira BioSciences	$0	$8,010,800 ▼	-100.0%	0	0.0%	Medical
Dyne Therapeutics Inc	$0	$7,940,250 ▼	-100.0%	0	0.0%	COM
FULC Fulcrum Therapeutics	$0	$7,192,000 ▼	-100.0%	0	0.0%	Medical
IOVA Iovance Biotherapeutics	$0	$2,406,000 ▼	-100.0%	0	0.0%	Medical
NAMS NewAmsterdam Pharma	$0	$480,250 ▼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vestal Point Capital, Lp Top Holdings and 13F Report (2024)

About Vestal Point Capital, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vestal Point Capital, Lp Top Holdings and 13F Report (2024)

About Vestal Point Capital, Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofVestal Point Capital, Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools